0554604 - ÚMG 2022 RIV US eng J - Journal Article
Gerckens, M. - Sarnová, Lenka - Jiroušková, Markéta - Gregor, Martin - Burgstaller, G. … Total 30 authors
Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics.
Science Advances. Roč. 7, č. 52 (2021), č. článku eabb3673. ISSN 2375-2548. E-ISSN 2375-2548
R&D Projects: GA MZd NV17-31538A; GA MŠMT(CZ) LQ1604; GA ČR GA18-02699S
Institutional support: RVO:68378050
Keywords : idiopathic pulmonary-fibrosis * growth-factor-beta * selective-inhibition * acute exacerbation * label-free * proteome * matrix * trial * mechanisms * tranilast
OECD category: Cell biology
Impact factor: 14.980, year: 2021
Method of publishing: Open access
https://www.science.org/doi/10.1126/sciadv.abb3673
Permanent Link: http://hdl.handle.net/11104/0329307
Gerckens, M. - Sarnová, Lenka - Jiroušková, Markéta - Gregor, Martin - Burgstaller, G. … Total 30 authors
Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics.
Science Advances. Roč. 7, č. 52 (2021), č. článku eabb3673. ISSN 2375-2548. E-ISSN 2375-2548
R&D Projects: GA MZd NV17-31538A; GA MŠMT(CZ) LQ1604; GA ČR GA18-02699S
Institutional support: RVO:68378050
Keywords : idiopathic pulmonary-fibrosis * growth-factor-beta * selective-inhibition * acute exacerbation * label-free * proteome * matrix * trial * mechanisms * tranilast
OECD category: Cell biology
Impact factor: 14.980, year: 2021
Method of publishing: Open access
https://www.science.org/doi/10.1126/sciadv.abb3673
Permanent Link: http://hdl.handle.net/11104/0329307